Publications

Investors - AUGUST 3, 2021

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

South Korea’s POBA commits to AXA IM’s €1.9b life sciences fund

by Kali Persall

IREI has learned that South Korea's Public Officials Benefit Association (POBA) contributed €80 million ($95 million) to AXA Investment Managers' life sciences fund, which recently hit €1.9 billion ($2.2 billion) of equity commitments.

The capital raised for AXA IM’s life sciences fund will primarily be invested through Kadans Science Partner, a fully integrated developer, owner and operator of European science parks and lab offices, which AXA acquired in December 2020.

According to The Korea Economic Daily, POBA made the investment through a co-investment fund of funds, which is managed by Kyobo AXA Investment Managers.

The fund of funds, known as Kyobo AXA Global Real Estate Co-investment Fund No.1, was established to invest in funds managed by AXA IM Alts, targeting emerging real estate sectors such as logistics, data centers, life science offices and

Forgot your username or password?